Selimoglu-Buet, Dorothée https://orcid.org/0000-0002-3565-2709
Chevret, Sylvie
Santini, Valeria https://orcid.org/0000-0002-5439-2172
Thépot, Sylvain
Morabito, Margot
Adès, Lionel https://orcid.org/0000-0002-9020-8766
Laplane, Lucie https://orcid.org/0000-0003-0185-3323
Giagounidis, Aristoteles
Droin, Nathalie https://orcid.org/0000-0002-6099-5324
Lübbert, Michael https://orcid.org/0000-0003-1186-1650
Sapena, Rosa
Nimubona, Stanislas
Torregrosa-Diaz, Jose Miguel
Germing, Ulrich
Pelizzari, Anna Maria
Park, Sophie
Jaekel, Nadja https://orcid.org/0000-0001-6162-515X
Metzgeroth, Georgia
Onida, Francesco https://orcid.org/0000-0002-2991-3474
Paul, Franciane
Patriarca, Andrea
Stamatoullas, Aspasia
Götze, Katharina https://orcid.org/0000-0002-6276-8002
Chermat, Fatiha
Platzbecker, Uwe https://orcid.org/0000-0003-1863-3239
Fenaux, Pierre
Solary, Eric https://orcid.org/0000-0002-8629-1341
Itzykson, Raphael https://orcid.org/0000-0003-2139-6262
Funding for this research was provided by:
Janssen Pharmaceuticals
Institut National Du Cancer (INCa-DGOS-INSERM-ITMO Cancer_18008)
Institut National Du Cancer (INCa_19428)
Association Laurette Fugain (ALF 2021/06)
Article History
Received: 17 September 2025
Revised: 19 January 2026
Accepted: 24 February 2026
First Online: 9 March 2026
Competing interests
: The authors declare no competing interests.